JANX Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 35.40%

Insider Buying (Last 12 Months): $11,156,442.66

Insider Selling (Last 12 Months): $164,250,000.00

Janux Therapeutics Insider Trading History Chart

Janux Therapeutics Share Price & Price History

^$41.89

▲ +1.55 (3.84%)

As of 06/28/2024 01:00 AM ET

Days: 30 | 90 | 365

Elon Musk’s chilling warning for humanity

From The Freeport Society | Ad

The 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern border is a travesty, but the 'invasion' I've found will have 10 times greater effects on our economy, and ultimately our way of life.

Go here to see why.

Janux Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/3/2024	Jay Lichter	Director	Sell	1,500,000	$54.75	$82,125,000.00	633,673
6/3/2024	Tighe Reardon	CFO	Sell	822,721	$54.75	$45,043,974.75	633,673
6/3/2024	Ventures Xi L.P. Avalon	Major Shareholder	Sell	677,279	$54.75	$37,081,025.25	3,271,216
11/13/2023	Ventures Xi L.P. Avalon	Major Shareholder	Buy	849,854	$5.87	$4,988,642.98	849,854
7/19/2023	Ra Capital Management, L.P.	Director	Buy	495,008	$12.46	$6,167,799.68	8,117,246

Biden Nomination CANCELED?

From The Freeport Society | Ad

And I believe when they do take the oath of office, their fingers will be crossed… and America will descend into chaos.

Click here now to see my urgent election warning.

SEC Filings (Institutional Ownership Changes) for Janux Therapeutics (NASDAQ:JANX)

75.39% of Janux Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Janux Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
5/20/2024	Virtu Financial LLC	16,183	$0.61M	0.0%	N/A	0.031%
5/17/2024	Artal Group S.A.	50,000	$1.88M	0.0%	N/A	0.096%
5/16/2024	California State Teachers Retirement System	16,263	$0.61M	0.0%	-5.4%	0.031%
5/16/2024	Janus Henderson Group PLC	1,965,546	$73.96M	0.0%	+1.8%	3.791%
5/16/2024	BVF Inc. IL	2,919,818	$109.93M	3.0%	-36.2%	5.631%
5/15/2024	Price T Rowe Associates Inc. MD	19,596	$0.74M	0.0%	N/A	0.038%
5/15/2024	Altitude Crest Partners Inc.	193,300	$7.28M	3.1%	N/A	0.373%
5/14/2024	StemPoint Capital LP	121,642	$4.58M	1.2%	N/A	0.235%
5/10/2024	Vanguard Group Inc.	1,357,960	$51.13M	0.0%	+38.6%	2.619%
5/9/2024	Lord Abbett & CO. LLC	542,373	$20.42M	0.1%	N/A	1.046%
5/8/2024	ProShare Advisors LLC	6,655	$0.25M	0.0%	N/A	0.013%
5/4/2024	Lester Murray Antman dba SimplyRich	7,964	$0.30M	0.1%	N/A	0.015%
5/1/2024	Capstone Investment Advisors LLC	52,300	$1.97M	0.0%	N/A	0.101%
4/30/2024	Allspring Global Investments Holdings LLC	6,349	$0.24M	0.0%	-75.8%	0.012%
4/29/2024	China Universal Asset Management Co. Ltd.	9,743	$0.37M	0.0%	+82.4%	0.019%
4/18/2024	Allspring Global Investments Holdings LLC	6,349	$0.24M	0.0%	-75.8%	0.012%
2/8/2024	Janney Montgomery Scott LLC	51,548	$0.55M	0.0%	N/A	0.112%
2/6/2024	Swiss National Bank	31,800	$0.34M	0.0%	+39.5%	0.069%
1/26/2024	Cerity Partners LLC	60,933	$0.65M	0.0%	N/A	0.132%
1/25/2024	Allspring Global Investments Holdings LLC	26,264	$0.28M	0.0%	+2,166.1%	0.057%
1/25/2024	Nisa Investment Advisors LLC	2,710	$29K	0.0%	+10,740.0%	0.006%
1/24/2024	China Universal Asset Management Co. Ltd.	5,343	$57K	0.0%	N/A	0.012%
1/12/2024	SG Americas Securities LLC	9,345	$100K	0.0%	N/A	0.020%
1/5/2024	Exchange Traded Concepts LLC	14,204	$0.15M	0.0%	+34.0%	0.031%
11/15/2023	RA Capital Management L.P.	9,165,652	$92.39M	1.8%	+5.7%	19.852%
11/15/2023	Adage Capital Partners GP L.L.C.	1,150,000	$11.59M	0.0%	+27.8%	2.491%
11/14/2023	Corton Capital Inc.	11,061	$0.11M	0.1%	N/A	0.024%
11/14/2023	Old Well Partners LLC	10,300	$0.10M	0.1%	N/A	0.022%
11/13/2023	FMR LLC	6,351,322	$64.02M	0.0%	+25.5%	13.756%
11/7/2023	Barclays PLC	17,922	$0.18M	0.0%	+227.1%	0.039%
9/21/2023	Barclays PLC	5,479	$65K	0.0%	-38.5%	0.012%
8/15/2023	BVF Inc. IL	4,106,945	$48.75M	1.4%	+159.0%	8.901%
8/14/2023	UniSuper Management Pty Ltd	138,888	$1.65M	0.0%	N/A	0.301%
7/20/2023	Exchange Traded Concepts LLC	10,010	$0.12M	0.0%	N/A	0.024%
5/16/2023	BVF Inc. IL	1,585,677	$19.19M	0.7%	+7.8%	3.790%
5/15/2023	EcoR1 Capital LLC	3,838,486	$46.45M	1.5%	+170.1%	9.176%
5/11/2023	FMR LLC	5,140,644	$62.20M	0.0%	-8.3%	12.289%
2/14/2023	Parkwood LLC	21,469	$0.28M	0.0%	-35.6%	0.052%
2/2/2023	SG Americas Securities LLC	7,902	$0.10M	0.0%	N/A	0.019%
11/8/2022	New York State Common Retirement Fund	13,259	$0.18M	0.0%	+65.5%	0.032%
8/16/2022	Woodline Partners LP	286,383	$3.50M	0.1%	+2.9%	0.687%
8/16/2022	Parkwood LLC	33,750	$34K	0.1%	+19.4%	0.081%
8/12/2022	FMR LLC	5,825,704	$71.13M	0.0%	+2.6%	13.984%
8/3/2022	DekaBank Deutsche Girozentrale	49,500	$0.57M	0.0%	N/A	0.119%
6/30/2022	Amalgamated Bank	1,928	$28K	0.0%	N/A	0.005%
5/5/2022	New York State Common Retirement Fund	15,521	$0.22M	0.0%	+63.0%	0.037%
2/19/2022	Woodline Partners LP	278,275	$5.49M	0.1%	-7.3%	0.669%
2/14/2022	Citadel Advisors LLC	1,853,432	$36.57M	0.0%	-0.3%	4.454%
2/11/2022	Parkwood LLC	32,128	$0.63M	0.1%	+54.6%	0.077%
2/8/2022	Northern Trust Corp	115,495	$2.28M	0.0%	-1.3%	0.278%
2/2/2022	New York State Common Retirement Fund	9,521	$0.19M	0.0%	+314.0%	0.023%
2/2/2022	DekaBank Deutsche Girozentrale	45,000	$0.89M	0.0%	N/A	0.108%
1/28/2022	Allspring Global Investments Holdings LLC	5,357	$0.11M	0.0%	N/A	0.013%
11/16/2021	Janus Henderson Group PLC	2,416,404	$51.38M	0.0%	-9.4%	5.807%
11/16/2021	Metropolitan Life Insurance Co NY	4,011	$87K	0.0%	N/A	0.010%
11/16/2021	BVF Inc. IL	1,017,314	$22.01M	0.9%	-13.5%	2.445%
11/16/2021	Citadel Advisors LLC	1,859,246	$39.64M	0.0%	-1.5%	4.468%
11/12/2021	Geode Capital Management LLC	211,880	$4.58M	0.0%	+862.3%	0.509%
11/10/2021	Citigroup Inc.	1,755	$38K	0.0%	-98.0%	0.004%
11/9/2021	BlackRock Inc.	801,778	$17.34M	0.0%	+629.2%	1.927%
11/4/2021	Deutsche Bank AG	8,185	$0.18M	0.0%	N/A	0.020%
11/2/2021	New York State Common Retirement Fund	2,300	$50K	0.0%	N/A	0.006%
11/1/2021	SG Americas Securities LLC	65,414	$1.42M	0.0%	N/A	0.157%
10/29/2021	Janney Montgomery Scott LLC	40,860	$0.88M	0.0%	N/A	0.098%
10/22/2021	Strs Ohio	3,000	$64K	0.0%	N/A	0.007%
8/17/2021	Woodline Partners LP	334,260	$8.34M	0.2%	N/A	0.803%
8/17/2021	Samsara BioCapital LLC	607,949	$15.17M	1.9%	N/A	1.461%
8/17/2021	Logos Global Management LP	547,122	$13.65M	1.2%	N/A	1.315%
8/17/2021	Millennium Management LLC	75,257	$1.88M	0.0%	N/A	0.181%
8/17/2021	BVF Inc. IL	1,176,681	$29.36M	1.1%	N/A	2.828%
8/17/2021	Citadel Advisors LLC	1,886,712	$46.24M	0.0%	N/A	4.534%
8/16/2021	5AM Venture Management LLC	446,266	$11.13M	2.8%	N/A	1.072%
8/16/2021	LMR Partners LLP	57,000	$1.42M	0.0%	N/A	0.137%
8/16/2021	RA Capital Management L.P.	8,670,644	$216.33M	3.5%	N/A	20.837%
8/16/2021	Pinz Capital Management LP	32,100	$0.80M	0.2%	N/A	0.077%
8/16/2021	Goldman Sachs Group Inc.	69,000	$1.72M	0.0%	N/A	0.166%
8/13/2021	Qube Research & Technologies Ltd	14,309	$0.36M	0.0%	N/A	0.036%
8/13/2021	Geode Capital Management LLC	22,017	$0.55M	0.0%	N/A	0.055%
8/13/2021	Vanguard Group Inc.	28,976	$0.72M	0.0%	N/A	0.073%
8/13/2021	FMR LLC	1,843,564	$46M	0.0%	N/A	4.620%
8/11/2021	BlackRock Inc.	109,947	$2.74M	0.0%	N/A	0.276%
8/10/2021	Citigroup Inc.	86,695	$2.16M	0.0%	N/A	0.217%

Data available starting January 2016

Janux Therapeutics, Inc., a clinical stage biopharmaceutical company, develops immunotherapies based on Tumor Activated T Cell Engagers (TRACTr) and Tumor Activated Immunomodulators (TRACIr) platforms technology to treat patients suffering from cancer. The company's clinical candidates comprise JANX007, a prostate-specific membrane antigen or PSMA-TRACTr, which is in Phase 1 clinical trial in adults for the treatment of metastatic castration-resistant prostate cancer (mCRPC) and the vasculature of other tumors; and JANX008, an epidermal growth factor receptor or EGFR-TRACTr that is in Phase 1 clinical trial for the treatment of multiple solid cancers, including colorectal cancer, squamous cell carcinoma of the head and neck, non-small cell lung cancer, and renal cell carcinoma. Its development pipeline also consists of discovery stage products. The company has strategic research collaboration agreement with Merck Sharp & Dohme Corp. to develop TRACTr product candidates. Janux Therapeutics, Inc. was incorporated in 2017 and is headquartered in San Diego, California.

Today's Range

Now: $41.89

$40.62

$42.15

50 Day Range

MA: $47.79

$39.80

$64.78

52 Week Range

Now: $41.89

$5.65

$65.60

Volume

2,670,348 shs

Average Volume

821,905 shs

Market Capitalization

$2.17 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

3.71

Who are the company insiders with the largest holdings of Janux Therapeutics?: Janux Therapeutics' top insider investors include:
Ra Capital Management, LP (Director)
Ventures Xi LP Avalon (Major Shareholder)
Jay Lichter (Director)
Tighe Reardon (CFO)
Learn More about top insider investors at Janux Therapeutics.